Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells

BACKGROUND: Airway inflammation is a key feature of chronic obstructive pulmonary disease (COPD) and inhaled corticosteroids (ICS) remain the main treatment for airway inflammation. Studies have noted the increased efficacy of ICS and long-acting beta 2 agonist (LABA) combination therapy in controll...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Respir Res
Glavni autori: Yang, Nan, Singhera, Gurpreet K., Yan, Yi Xuan, Pieper, Michael P., Leung, Janice M., Sin, Don D., Dorscheid, Delbert R.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7901009/
https://ncbi.nlm.nih.gov/pubmed/33622325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-021-01659-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items